Probiotics as functional foods: How probiotics can alleviate the symptoms of neurological disabilities

被引:14
作者
Aghamohammad, Shadi [1 ]
Hafezi, Asal [1 ]
Rohani, Mahdi [1 ,2 ]
机构
[1] Pasteur Inst Iran, Dept Bacteriol, Tehran, Iran
[2] 12th Farvardin,Pasteur Sq, Tehran, Iran
关键词
Functional foods; Probiotics; Inflammation; Neurological disabilities; MAJOR DEPRESSIVE DISORDER; GUT MICROBIOTA; ALZHEIMERS-DISEASE; INTESTINAL PERMEABILITY; PARKINSONS-DISEASE; RISK-FACTORS; MOUSE MODEL; MIGRAINE; ETIOLOGY; NEUROINFLAMMATION;
D O I
10.1016/j.biopha.2023.114816
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Neurological disorders are diseases of the central nervous system with progressive loss of nervous tissue. One of the most difficult problems associated with neurological disorders is that there is no clear treatment for these diseases. In this review, the physiopathology of some neurodegenerative diseases, etiological causes, drugs used and their side effects, and finally the role of probiotics in controlling the symptoms of these neurodegenerative diseases are presented. Recently, researchers have focused more on the microbiome and the gut-brain axis, which may play a critical role in maintaining brain health. Probiotics are among the most important bacteria that have positive effects on the balance of homeostasis via influencing the microbiome. Other important functions of probiotics in alleviating symptoms of neurological disorders include anti-inflammatory properties, short-chain fatty acid production, and the production of various neurotransmitters. The effects of probiotics on the con-trol of abnormalities seen in neurological disorders led to probiotics being referred to as "psychobiotic. Given the important role of the gut-brain axis and the imbalance of the gut microbiome in the etiology and symptoms of neurological disorders, probiotics could be considered safe agents that positively affect the balance of the microbiome as complementary treatment options for neurological disorders.
引用
收藏
页数:11
相关论文
共 112 条
  • [1] The Promising Role of Probiotics in Managing the Altered Gut in Autism Spectrum Disorders
    Abdellatif, Basma
    McVeigh, Clare
    Bendriss, Ghizlane
    Chaari, Ali
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 1 - 24
  • [2] Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
    Achtyes, Eric
    Simmons, Adam
    Skabeev, Anna
    Levy, Nikki
    Jiang, Ying
    Marcy, Patricia
    Weiden, Peter J.
    [J]. BMC PSYCHIATRY, 2018, 18
  • [3] The potential role of Bifidobacterium spp. as a preventive and therapeutic agent in controlling inflammation via affecting inflammatory signalling pathways
    Aghamohammad, S.
    Sepehr, A.
    Miri, S. T.
    Najafi, S.
    Pourshafie, M. R.
    Rohani, M.
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 2022, 75 (05) : 1254 - 1263
  • [4] Anti-inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control
    Aghamohammad, Shadi
    Sepehr, Amin
    Miri, Seyedeh Tina
    Najafi, Saeideh
    Pourshafie, Mohammad R.
    Rohani, Mahdi
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (06)
  • [5] The effects of the probiotic cocktail on modulation of the NF-kB and JAK/STAT signaling pathways involved in the inflammatory response in bowel disease model
    Aghamohammad, Shadi
    Sepehr, Amin
    Miri, Seyedeh Tina
    Najafi, Saeideh
    Rohani, Mahdi
    Pourshafiea, Mohammad R.
    [J]. BMC IMMUNOLOGY, 2022, 23 (01)
  • [6] Molecular diagnostics of neurodegenerative disorders
    Agrawal, Megha
    Biswas, Abhijit
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2015, 2
  • [7] Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial (Publication with Expression of Concern)
    Akbari, Elmira
    Asemi, Zatollah
    Kakhaki, Reza Daneshvar
    Bahmani, Fereshteh
    Kouchaki, Ebrahim
    Tamtaji, Omid Reza
    Hamidi, Gholam Ali
    Salami, Mahmoud
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2016, 8
  • [8] Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
    Akkasheh, Ghodarz
    Kashani-Poor, Zahra
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Akbari, Hossein
    Taghizadeh, Mohsen
    Memarzadeh, Mohammad Reza
    Asemi, Zatollah
    Esmaillzadeh, Ahmad
    [J]. NUTRITION, 2016, 32 (03) : 315 - 320
  • [9] Anxiety, depression, and comorbid anxiety and depression: risk factors and outcome over two years
    Almeida, Osvaldo P.
    Draper, Brian
    Pirkis, Jane
    Snowdon, John
    Lautenschlager, Nicola T.
    Byrne, Gerard
    Sim, Moira
    Stocks, Nigel
    Kerse, Ngaire
    Flicker, Leon
    Pfaff, Jon J.
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2012, 24 (10) : 1622 - 1632
  • [10] Gut-brain Axis and migraine headache: a comprehensive review
    Arzani, Mahsa
    Jahromi, Soodeh Razeghi
    Ghorbani, Zeinab
    Vahabizad, Fahimeh
    Martelletti, Paolo
    Ghaemi, Amir
    Sacco, Simona
    Togha, Mansoureh
    [J]. JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01)